Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS
Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS for the Prevention of Gastric Variceal Rebleeding in Patients With Liver Cirrhosis: A Prospective, Randomized, Controlled Trial
Sponsor: Air Force Military Medical University, China
Listed as NCT04198259, this NA trial focuses on Gastric Varices Bleeding and Liver Cirrhoses and remains ongoing. Sponsored by Air Force Military Medical University, China, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Feb 2023 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
▶ Show 3 earlier versions
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Not Yet Recruiting NA
-
Jan 2020 — Mar 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.